Please check your internet connection and try again.
# Dexamethasone in Chronic ITP
## Overview
Dexamethasone is a potent, long-acting glucocorticoid used for immunosuppression in immune thrombocytopenia (ITP). In chronic ITP, pulsed high-dose dexamethasone is employed to rapidly increase platelet counts and induce remission.
## Primary Indications
- Second-line therapy for adult chronic ITP (after corticosteroids or IVIG)
- First-line for newly diagnosed ITP (as an alternative to prednisone)
- Bridging therapy before splenectomy or rituximab
- Rescue therapy for bleeding or pre-surgery
## Adult Dosing
- **High-dose pulse:** Dexamethasone 40 mg PO/IV daily for 4 consecutive days, repeated every 14-28 days for up to 4-6 cycles if responding
- **Alternative:** 40 mg PO/IV daily for 4 days, monthly for 6 cycles (per local protocols)
- Some protocols combine with rituximab or other agents
Dosing protocols vary by institution; confirm local guidelines.
## Pediatric Dosing
- Limited evidence; some centers use 20-28 mg/m²/day (max 40 mg/day) PO/IV for 4 days per cycle
- Alternatively: 0.6-1 mg/kg/day for 3-4 days per cycle
- Regimen should follow pediatric hematology specialist guidance
## Dose Adjustments
- **Renal/hepatic impairment:** No standard dose adjustment; monitor for fluid retention and glucose intolerance
- **Elderly:** Lower initial doses due to increased risk of osteoporosis, hyperglycemia, and infection
- **Active infection:** Caution; may require delay of therapy
## Contraindications
- Systemic fungal infection
- Known hypersensitivity to dexamethasone or components
- Active untreated tuberculosis
- Severe immunocompromise without appropriate prophylaxis
- Relatively: poorly controlled diabetes, uncontrolled hypertension, herpes simplex keratitis
## Adverse Effects
- **Common:** Hyperglycemia, insomnia, mood changes, increased appetite, fluid retention, hypertension
- **Serious:** Adrenal suppression (with prolonged or repeated courses), osteoporosis, aseptic necrosis of femoral head, peptic ulcer, cataracts, immunosuppression/increased infection risk
- **Psychiatric:** Psychosis, euphoria, depression (dose-dependent)
## Key Drug Interactions
- **Anticoagulants/Antiplatelets:** Use cautiously due to bleeding risk; monitor platelets closely
- **Aspirin/NSAIDs:** Increased gastrointestinal bleeding risk
- **CYP3A4 inducers (phenytoin, rifampin, carbamazepine):** Decrease dexamethasone efficacy
- **CYP3A4 inhibitors (ritonavir, azole antifungals):** May increase dexamethasone exposure
- **Live vaccines:** Avoid; use inactivated vaccines with caution
## Monitoring
- Baseline and periodic: platelet count, glucose, blood pressure, weight, electrolytes
- Signal for response: platelet count increase within 3-7 days of cycle
- Long-term: bone density (if repeated cycles), ophthalmologic exam, adrenal function after multiple cycles
## Clinical Pearls
- High-dose dexamethasone pulse can produce rapid platelet rise (peaks around day 5-7)
- Use for 4 days per cycle; skipping days between cycles reduces cumulative glucocorticoid toxicity
- Dexamethasone may be superior to prednisone for longer remission in some patients
- Consider proton pump inhibitor prophylaxis for GI protection
- Always taper if prior or prolonged corticosteroid use is present to avoid adrenal crisis
- Response and duration of remission variable; some patients achieve long-term remission after 1-2 cycles
---
*This information is for educational purposes. Dexamethasone dosing in chronic ITP is evolving and protocol-dependent. Always verify current prescribing information, local guidelines, and consult a specialist before initiating therapy.*
